| Sources | Names Used |
|---|---|
| GDSC1000 | MPS-1-IN-1 |
| PharmacoGx | MPS-1-IN-1 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IL17F | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-17 |
| mRNA | TMEM260 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-16 |
| mRNA | HAVCR2 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-16 |
| mRNA | AMER2 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-15 |
| mRNA | MTMR7 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-15 |
| mRNA | GPR84 | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-15 |
| mRNA | HTRA3 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-15 |
| mRNA | CD163 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-14 |
| mRNA | AQP9 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-14 |
| mRNA | IL2RA | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-14 |
